North German SME has developed diagnosis tool which enables customization of pharmaceuticals, supplements and/or sleep Publish date: Monday, June 08, 2026 SME from northern Germany developed a clinically validated diagnostic translating an individuals inner biological clock into actionable guidance to optimise medical treatment, sleep, nutrition and overall health. Partners in healthcare, pharmaceuticals, digital health, diagnostics, and consumer health industries are sought further development, integration and upscaling across clinical and non-clinical use cases. TODE20260429010 ReadMore A French manufacturer of CBRN PPE and rapid individual decontamination solutions is looking for partners in Europe Publish date: Wednesday, April 08, 2026 A French SME in Lyon designs and manufactures CBRN PPE (air permeable suits, overboots, gloves, respiratory protection) and rapid individual decontamination kits for liquid and particulate contamination. The company also offers a smart ready PPE platform (sensors, mixed reality training) and certification expertise (EU 2016/425). The Company has a strong experience in EU projects and is looking for new partners in Europe to build consortia for EU calls (Horizon Europe, EDF, Eurostars). TOFR20260331027 ReadMore A Finnish SME is searching for franchisees for their respiratory infection testing platform and solution Publish date: Monday, March 23, 2026 A Finnish SME has developed a platform and solutions for healthcare service providers for offering professional respiratory infection testing directly to consumers. The tests help to identify the pathogen and enable the doctor to prescribe the appropriate treatment. The company is looking for pharmacy chains or retailers, online doctor services or minute clinic chains, or other healthcare service providers to become franchisees. BOFI20260210019 ReadMore A Dutch-British biotech company discovered novel immuno-therapeutic targets for pancreatic cancer and is now looking for financial partners Publish date: Wednesday, March 18, 2026 A Dutch-British company is specilaized in preclinical research for drug developing companies. Recent outcome of internal research on post-translational modification of immune cells, in particular macrophages, has developed into an immuno-therapeutic target for pancreatic cancer. They gained a groundbreaking solution and financial partners, resources and funding are sought to advance to the next phase. An investment agreement or a strategic R&D cooperation agreement is foreseen. BONL20260310018 ReadMore
Wednesday, July 22, 2020 Prevalje site - Unique opportunity to kick-start your business with expansion options - More...
Agriculture Textile / Leather / Footwear Wood and Furniture Paper / Paper Products Publishing and Printing Chemical Industry Rubber and Plastic Pharmaceutics / Medical Equipment Glass / China / Ceramics Metal (Production and Processing) Machinery and Equipment Electro Industry Motor Vehicles and Spare Parts Construction Technology Transport Business Consulting Information and Telecommunication Accounting Services Design / Engineering Education Premises / Real Estate Catering / Tourism Other Waste Material